Skip to main content
Indian Dermatology Online Journal logoLink to Indian Dermatology Online Journal
. 2024 Oct 28;15(6):920–929. doi: 10.4103/idoj.idoj_111_24

Topical Sunscreens: A Narrative Review for Contact Sensitivity, Potential Allergens, Clinical Evaluation, and Management for their Optimal Use in Clinical Practice

Vikram K Mahajan 1,, Neeraj Sharma 1, Vikas Sharma 1, Rohit Verma 1, Monika Chandel 1, Ravinder Singh 1
PMCID: PMC11616936  PMID: 39640469

Abstract

Topical sunscreens decrease the quantity of ultraviolet (UV) light from the sun reaching the skin by either blocking or scattering it and help protect the skin from dyspigmentation, photoaging, DNA damage, and photocarcinogenesis, especially in photosensitive individuals. The significant role played by visible light and infrared light in skin pigmentation and photoaging has been recognized in recent years. The majority of broad-spectrum sunscreens protect against UV-B (290–320nm) and UV-A (320–400nm) radiation. Allergic reactions to sunscreens were relatively uncommon compared to their widespread use in the last more than four decades. With growing awareness of problems associated with excessive sunlight exposure, their use has increased exponentially, especially that of cosmetics and other personal grooming products containing UV filters. In recent years, sunscreen agents have been commonly identified as causing allergic contact dermatitis and photodermatitis. Thus, allergic contact dermatitis, photo-irritation, photo-allergenicity, and photo-toxicity (acute/subacute effects) are of immediate concern in the assessment of topical sunscreens for their optimal use. Sunscreen chemicals such as p-aminobenzoic acid (PABA) and PABA esters, the cinnamates, benzophenones, oxybenzone, and dibenzoylmethane that absorb UV radiation are common contact sensitizers capable of producing both allergic contact dermatitis and photodermatitis. The excipients in sunscreen formulations by themselves may also cause allergic reactions. Herein, we review potential allergens, clinical evaluation, and management aspects of topical sunscreen contact sensitivity for their optimal use in clinical practice.

Keywords: Allergic contact dermatitis, benzophenones, cinnamates, dibenzoylmethane, octocrylene, oxybenzone, PABA, photoallergic contact dermatitis, photoprotection, salicylates, sunscreens, UVA filters, UVB filters

Introduction

Topical sunscreens reduce the quantity of solar ultraviolet radiation (UVR) by blocking or scattering it and protecting the skin of photosensitive individuals. As melanin intrinsically protects skin from sunlight, its harmful effects occur earlier in persons with lighter skin. However, prolonged sun exposure eventually causes photodamage, photoaging, and skin cancer, warranting optimum photo protection with topical sunscreens. Although transient stinging, urticaria, and acne from topical sunscreens may happen immediately, sunscreens have been identified as a common cause of allergic contact dermatitis (ACD) and photoallergic contact dermatitis (PACD) from their increased usage, resulting from growing awareness about the hazards of excessive sunlight exposure.[1,2,3] Thus, photo-toxicity, photo-irritation, and photo-allergenicity (acute/subacute effects), photo-genotoxicity, and photo-carcinogenicity (chronic effects), along with allergic reactions from excipients, perfumes, and preservatives, remain major concerns for the assessment of sunscreen formulations.[4,5] Herein, we review potential allergens, clinical evaluation, and management aspects of topical sunscreen contact sensitivity for their optimal use in clinical practice.

Sunlight and Its Photobiologic Effects

It will be prudent to recapitulate the sunlight spectrum that consists of both visible and invisible light rays, the UVR. UVR is only 5% of the sunlight reaching the earth and is defined by wavelength and frequency. It comprises of UV-A (UV-A1, 340–400nm and UV-A2, 320–340nm), UV-B (280–320nm), and UV-C (200–280nm). UV-C of wavelengths ≤290nm is absorbed in the ozone layer of the atmosphere, UV-B gets strongly attenuated, and UV-A is transmitted almost unaffected. The UVR falling on earth is 90% UV-A and 10% UV-B, whereas ≈44% of sunlight is visible radiation.[6] Irradiance of UV-A is nearly 17 times higher than UV-B, irrespective of weather conditions. Clouds block only ≈20% of UVR. Window glass in buildings/automobiles filters out UV-B but not UV-A and can transmit nearly 0.1‒72% of UVR, depending on its type and thickness. A high prevalence of photodamage, actinic keratosis, melanoma in situ, and non-melanoma skin cancers is reported over skin exposed directly to UVR from automobile windows.[7,8,9] About 5% of UVR and visible radiation reaching the skin is diffusely reflected and the remaining gets transmitted, scattered, absorbed, or passed out. UVR penetrates skin 1.5‒90 μm deep in comparison to 90–750 μm for visible light.[6] Patients can be sensitive to the whole spectrum but mostly to UV-B, which manifests as erythema, sunburn, and photo-carcinogenesis.[6] The UV-A causes immediate tanning, photoaging, and wrinkling. Visible light produces immediate erythema in persons with Fitzpatrick’s skin type II and tanning and persistent pigmentation among those with skin types III–VI.[9,10,11] The infrared light and visible light, predominantly the high-energy blue light (380–455nm), have photodamaging and photoaging effects.[9] Although visible/blue light from computer/smartphone screens is 100‒1000 times less intense than sunlight, it may worsen melasma by interacting with potential photoallergens.[12] The synergistic effect of visible light and UV-A1 and their possible role in inducing melanogenesis and skin pigmentation too has been elucidated recently.[11,13,14]

Sunscreens

Historically, the need for protection against sunlight has been felt since antiquity.[15,16,17] Modern sunscreens became commercially available in the 1930s, and several chemicals, either alone or in combinations, have been used in sunscreens since then. Sunscreens include two basic types: physical sunscreens and chemical sunscreens. Titanium dioxide, zinc oxide, and ferric oxide, the main mineral constituents in physical or inorganic (mineral) sunscreens, provide comprehensive sun protection by reflecting or scattering UVR and visible/blue light, improve hyperpigmenation, and prevent relapses in melasma more effectively than chemical sunscreens.[18] The exact ratio of each mineral determines the tint; darker shades have ferric oxide in a higher percentage.[6] Their current formulations containing nano sized (<100 nm) mineral constituents make them transparent and cosmetically pleasing. They act as physical barriers and are ideal for outdoor workers or those who need absolute sun protection. Zinc oxide and titanium dioxide are non-irritant/allergenic and do not cause phototoxicity/photoallergy but contact allergy from excipients such as parabens remains possible.[19]

The chemical sunscreens are practically transparent and cosmetically more acceptable. They offer protection from UV-B. But protection from UV-A and visible ranges is only partial. However, quantification of UV-A protection remains difficult in combination formulations. Chemical sunscreens have been used in Europe and the USA since the 1930, when sunbathing became fashionable. It is only in the last two decades that their use primarily for UV protection has increased rapidly worldwide for want of lighter skin and increasing awareness of the harms of sunlight. Consequently, ACD and PACD can occur frequently from many of the sunscreen ingredients.[20,21,22,23]

Epidemiology

The exact prevalence of sunscreen sensitivity in India remains understudied, and its actual prevalence is generally considered low despite widespread use for sun protection or in personal care products. A low concentration of sunscreen chemicals used for patch testing to avoid irritant reactions is a frequently cited reason.[24] However, the photopatch test procedure itself may appear cumbersome for routine practice, discouraging confirmation of sunscreen photosensitivity. Moreover, many cases of sunscreen-induced photosensitivity and primary photodermatoses for which the sunscreen was used remain indistinguishable.[20] However, there are several reports of sunscreen-induced ACD and PACD. The prevalence of sensitivity from active sunscreen chemicals was 0.8% in a Canadian report from 2014, while the North American Contact Dermatitis Group (NACDG) reported about 1% positive patch test reactions among patients tested during 1998‒2004.[25,26,27,28] In a retrospective analysis of 23908 patients patch tested during 2001‒2010 by NACDG, 0.9% of positive reactions were from sunscreen chemicals, mainly benzophenone-3.[29] The prevalence of PACD from sunscreen agents also appears high. Of the 2715 patients evaluated for photosensitivity disorders during 1983‒1998, photoallergic reactions happened in 2.3%, and 65% of them were from sunscreen agents, while 68% of the other 49 patients had non-photoallergic reactions.[30] Schauder and Ippen[5] reported that 20% of 402 German patients with suspected photosensitivity were allergic to UV filters in sunscreens or cosmetics. Journe et al.[31] observed 15.4% positivity from sunscreens among 370 French patients evaluated for photodermatitis. A Singaporean study reported photodermatitis in 4.2% of 48 patients, and positive patch test reactions in 6.3% were from sunscreen chemicals.[32] Similar results were also reported in 19 Australian patients evaluated by photopatch testing.[33]

Although ACD from sunscreens in infants has been reported, sunscreen sensitivity in children is overall uncommon.[5,34,35] Among 157 children under photo-investigation, 6.4% had photoallergy. Sunscreen chemicals/cosmetics caused sensitivity in 5.7% of them, and benzophenone-3 was the commonest sensitizer.[36] Ferriol and Boniche[35] reported butyl-methoxydibenzoylmethane and octyl-methoxycinnamate contact sensitivity in a young girl. Benzophenone-3 and methoxycinnamate caused contact sensitivity in another child.[33] Octocrylene is another emerging cause of ACD in children.[37]

Risk Factors

The exposure is either from sunscreens used for recreational activity, such as at the beach or from the daily application of skin, lip, and hair cosmetics containing UV filters. Their recent use is also in paints, plastic and rubber products, clothing and the fabric industry, and post cosmetic procedures.[21] Although risk factors remain poorly defined, sunscreen contact sensitivity has become manifold with its increasing use in general. In a study of 80 patients with photodermatoses a high prevalence of 65% of women with ACD or PACD was attributed to their higher use of cosmetics/sunscreens.[5] Sunscreens used by individuals working outdoors for long hours or over previously damaged skin, as in atopic dermatitis or after cosmetic procedures are more likely to cause contact sensitivity.[3,20] Children with atopic dermatitis are particularly at high risk.[3]

Sunscreen Allergens

The contact sensitivity is almost exclusive to chemical sunscreens or their excipients. Table 1 lists common chemical agents in sunscreens.

Table 1.

Chemical sunscreens

Sunscreen chemicals UV spectrum (nm) Concentration in topical formulations (%)
PABA and PABA esters UVB
• PABA 260–313 5–15
• Ethyl-dihydroxy-propyl-PABA 280–330 1–5
• Padimate-O (octyl dimethyl PABA) 290–315 1.4–8
• Glyceryl PABA 264–315 2–3
Cinnamates UVB
• Cinoxate 27–328 1–3
• Ethyhexyl p-methoxy-cinnamate 290–320 2–7.5
• Octocrylene 250–360 7–10
• Octinoxate (octylmethoxy cinnamate) 290–320 7.5
Salicylates UVB
• Octyl salicylate 280–320 3–5
• Ethyhexyl salicylate 280–320 3–5
• Homsalate 295–315 4–15
Benzophenones UVA and UVB
• Oxybenzone (benzophenone 3, Eusolex 4360) 270–352 2–6
• Dioxybenzone 260–380 3
• Sulisobenzone (benzophenone 4) 320–350 5–10
Others UVB
• Methyl anthranilate 260–380 3.5–5
• Digalloyl triolate 270–320 2–5
• Methylene-bis-benzotriazole tetra-methylbutylphenol (Tinsorb M) 320–350 5–10
• Bis-ethylhexyloxyphenol methoxy-phenol triazine (Tinsorb S) 305–360 1–5
• Drometrizole trisiloxane 311–313 10–15
• Octyl triazone 280–320 5
• Butyl-methoxy-dibenzoyl methane (Avobenzone, Parsol 1789) UVA (320–400) 3–5
• Isopropyldibenzoylmethane (Eusolex 8020)*
• Anthranilates 320–400 5

*This has been removed from the list of sunscreen agents in 1993 due to high photosensitivity reactions

Para-aminobenzoic Acid (PABA), PABA-esters

PABA and PABA-esters, the earliest UV-B blockers commercialized in the USA, were identified to cause sensitivity as early as 1947. Transient stinging/burning from PABA-containing products is common but ACD and PACD are the main reasons for their declining use. Yet, their use in sunscreens is permitted up to a concentration of 5% in Europe and 10% in the USA.[22,38] PABA-esters include amyldimethyl-PABA (Padimate-A®), ethylhexyl-dimethyl-PABA (Padimate-O®), and glycerol-PABA. They are less commonly photoallergenic than PABA.[22] However, only Padimate-O® is used despite the risk of photoallergy.[39] The photoallergenicity of PABA is attributed to quinine amines, products of its oxidation from photoactivation or photodegradation.[20]

Cinnamates

Cinnamates, the oil-soluble UV-B blockers, have been popularized for water-resistant sunscreens and are often used in combination with benzophenones. They infrequently cause ACD but are the third most common cause of PACD after oxybenzone and avobenzone (4-tert-butyl-4-methoxydibenzoylmethane/ Parsol-1789).[40,41] Octylmethylcinnamate (ethylhexyl-p- methoxycinnamate/Parsol MCX), the most used cinnamate, is negligibly irritant and less photoallergenic.[41,42] Schauder and Ippen[5] reported ACD in seven and photoallergy in 14 of 402 patients from octylmethylcinnamate and infrequently used isoamyl-p-methoxycinnamate (cinoxate, Neo Heliopan).

Octocrylene, a sunscreen agent chemically related to cinnamates with water-resistant properties, was introduced to substitute highly sensitizing oxybenzone. It is photostable and a photostabilizer for other cinnamates and butyl-methoxydibenzoylmethane. Most high-sun protection factor (SPF) sunscreens today contain octocrylene, which has broad spectrum UVR absorption within the UV-B to UV-A2 range. It has been associated with the rising prevalence of ACD and PACD in adults and contact urticaria and ACD in children, notably reported from France, Belgium, Spain, and Italy.[3,43,44,45,46] It is a strong allergen and not recommended for children and individuals sensitive to other cross-reacting agents (vide infra).[22]

Salicylates

Salicylates, weak UV-B absorbers, are water-insoluble and used in high concentrations or incorporated into other cosmetics. ACD from salicylates is uncommon, and even high concentrations are considered safe. Presently, octylsalicylate (2-ethyl-hexyl-salicylate) is commonly used and perhaps an emerging contact sensitizer.[45] Octylsalicylate has been reported to cause both ACD and PACD.[47]

Other UV-B blockers include drometrizole trisiloxane, octyltriazone, and methylene-bis-benzotriazolyl tetramethylbutylphenol (MBBT or Tinosorb M®), a phenolic benzotriazole that stabilizes other UV absorbers. These are new UV-B and UV-A filters, and infrequently cause ACD and PACD.[48,49,50] Phenylbenzimidazole sulfonic acid and 3,4’- methylbenzylidene camphor (Parsol 5000/Eusolex 6300), presently authorized in Europe, are rare causes of ACD and PACD when used in combination with another strong allergen (coupling allergy).[51]

Benzophenones

Benzophenone-1 to benzophenone-10 are primarily UV-B filters and absorb UV-B to UV-A2 (321-340nm) spectrum.[52] They are commonly incorporated in cosmetics (shower gels, nail varnish, and daily moisturizers) and as preservatives in textiles, paints, plastics, and rubber products to prevent photo-discoloration. They are slightly irritating, non-sensitizing, and phototoxic in human and animal studies.[4] Benzophenone was the commonest allergen in up to 0.6% of positive reactions, and benzophenone-3 was a relevant allergen in 70% of positive reactions during 2003‒2004.[28] Contact sensitivity has been increasing proportionately with their growing use, and they were even named the “allergen of the year” for 2014.[52] Benzophenone-3 (syn. oxybenzone, Eusolex 4360, methanone, Uvinul M40, and diphenylketone), an emerging environmental contaminant, is a commonly used sunblocker. It causes the highest incidence of PACD, accounting for 12‒21% of positive photopatch tests across studies where the exposure was mainly from daily moisturizers.[5,28,41,42,53] Benzophenone-3 has been reported to cause erythema multiforme-like rash, PACD, contact/photocontact urticaria, and anaphylaxis with a positive skin-prick test.[54,55,56,57,58,59] However, at 1‒6% concentration, it was not a significant sensitizer/irritant.[60] Benzophenone-4 (sulisobenzone) has elicited positive reactions in 2.3% of 1693 patients patch-tested with a cosmetic series and was the third most common allergen among other UV filters including benzophenone-3.[23] Benzophenone-3, benzophenone-8, and benzophenone-10 had reportedly caused painful, pruritic, and edematous eruptions and anaphylactoid reactions with recurrence during patch testing.[61]

Dibenzoylmethane Derivatives

Isopropyl-dibenzoylmethane (Eusolex 8020) and 4-tert-butyl-4-methoxydibenzoylmethane (avobenzone/Parsol 1789) are better UV-A blockers and not bereft of contact or photoallergy. Contact sensitivity and positive patch tests/photopatch tests have been reported from Germany, England, France, Italy, and the USA, making it the second most common allergen after benzophenone-3.[5,40,41,62]

Cross Reactions

Cross-reactions among sunscreen agents or with other structurally similar chemicals are not uncommon and necessitate the avoidance of sunscreen agents for individuals sensitive to either of them. Cross-reactions are common with PABA and p-phenylenediamine, benzocaine, sulfonamides, and azo dyes due to structural similarity. The significant feature of cinnamates is their cross-reactions with fragrances/flavoring agents (balsam of Peru, cinnamic aldehyde, and cinnamon oil). Octocrylene is distinct for frequent cross-reactions with ketoprofen, cis-3-hexenylsalicylate, benzophenone-3, and other cinnamates.[22,47] Cross-reactions within the benzophenone group are unproven. However, multiple contact allergies to benzophenone-3, benzophenone-4, and benzophenone-8 have occurred.[53,54]

Allergy to Excipients

Excipients in sunscreen products are important for efficacy, and most allergic/photoallergic reactions are from emollients (isohexadecane, isopropyl myristate, polyethylene glycol-7-hydrogenated castor oil), emulsifiers (wool alcohols, tetrahydroxypropyl ethylenediamine, triethanolamine, and pentylene glycol), surfactants (decyl glucoside, lauryl glucoside), preservatives (Euxyl K400, benzoic acid, ethylhexylglycerin), perfumes, and copolymers.[20,22] The frequency of patch test positivity from cinnamic aldehyde, a perfume, was 2.3% and 3.6% in two large studies.[20,28] Copolymers such as C30-38 olefin/isopropyl maleate/MA, polyvinylpyrrolidone (PVP)/hexadecane, PVP/eicosene, and PVP/1-triacontene added in sunscreens/cosmetics as skin conditioning, antistatic, emulsion-stabilizing, and film-forming agents to enhance water/sweat resistance may cause ACD.[63,64,65,66,67] Surfactant decyl glucoside, and xanthan gum, a thickening agent with skin hydrating, conditioning, and gel-forming effects, are common constituents of Tinosorb®M sunscreen and causes of ACD.[68,69,70] Polycrylene (Polyester-8®), a photostabilizer having structural similarities to octocrylene, in a sunscreen moisturizer too has caused ACD.[71] Aluminum in cosmetics and mineral sunscreens, added as an absorbent, pigment carrier, anticaking agent, and bulking agent for titanium dioxide to improve spreadability, has also caused ACD.[72,73]

Clinical Manifestations

The most common clinical presentation of sunscreen sensitivity is eczema of variable severity localized to sites exposed to sunlight and sunscreen application: the face, anterior neck, dorsal hands, and forearms. Acute eczema occurs more frequently, but it can be subacute or chronic and often simulates PACD. However, the non-sun-exposed skin (retroauricular skin, upper eyelids, upper lip, and submental region) remains spared in PACD. Unilateral dermatitis or dermatitis localized to a body site can occur where the sunscreen was applied or sun exposure has been prolonged. Contact dermatitis may occur from the passive transfer of a sensitizing sunscreen product with strong allergenic potential from one body site to another or from contact with another person who has applied it (consort dermatitis).

Isoamyl-p-methoxycinnamate has been reported to cause polymorphic urticated and papular eruptions on sun-exposed skin sparing face and hands, as well as acrofacial photodermatitis with positive patch and photopatch reactions.[74,75] Contact urticaria with anaphylaxis from benzophenones and contact urticaria from octocrylene have occurred.[46,61] Allergic contact cheilitis is reported from benzophenone-3 in lip balm.[76] Pustular ACD in a child with pustular psoriasis in-remission occurred from triethanolamine, an emulsifier in her sunscreen.[77] Ethylhexyl salicylate and drometrizole trisiloxane containing sunscreens have caused ACD as well as frontal fibrosing alopecia.[48,78,79] Oxybenzone has caused erythema multiforme-like PACD.[56]

Diagnosis

A lack of clinical suspicion often delays the diagnosis, and the presence of dermatitis itself is not diagnostic. The common differentials include polymorphous light eruptions (PLE), persistent-light reactions, chronic actinic dermatitis (CAD), lupus erythematosus (LE), and porphyrias. Common clues to a sunscreen allergy include a poor therapeutic response or worsening of primary photodermatosis following sunscreen usage. Patients with suspected cosmetic dermatitis, particularly with photo-aggravation, photo-distributed dermatitis, and/or changing clinical patterns, especially in at-risk individuals (vide supra), need investigations for sunscreen allergy. Thus, a detailed medical history and clinical examination, along with patch/photopatch testing serially with a sunscreen series, baseline series, cosmetic series, and patient’s cosmetics, remain the preferred diagnostic approach. Evaluation by both standard patch testing and photopatch testing is warranted, as some cases of true sunscreen sensitivity can be missed if only patch testing is done.

Patch Testing and Photopatch Testing

Some cases of true sunscreen sensitivity can be missed if only patch testing is done, thus warranting evaluation by both standard patch testing and photopatch testing. Petrolatum remains a vehicle of choice for sunscreen antigens, but its utility may remain limited due to the bioavailability of test antigens; ethanol detects PABA sensitivity better.[20]

Sunscreen ACD may occur from hypersensitivity to the photoprotective chemical itself, excipients, or the vehicle. In suspected cosmetic dermatitis or photodermatitis, patch testing with a baseline cosmetic series including fragrances and preservatives should be done for screening and with a sunscreen series [Tables 2 and 3] along with the putative product(s) for confirmation. Sometimes, photoallergy can occur from benzophenones used in combination with cinnamates or avobenzone and not from an individual chemical.[80] This reflects that some “co-allergic” patients react to sunscreen agents in a specific combination and not to a single agent, necessitating additional testing with the patient’s own cosmetics.

Table 2.

Indian sunscreen series*

Patch test antigens Conc. (w/w) Veh.
p-tert-butyl-4-methoxy-dibenzoyl-methane 10% pet
Homosalate 5% pet
PABA 10% pet
3-(4-methylbenzyliden) camphor 10% pet
2-ethylhexyl-4-dimethyl-aminobenzoate 10% pet
Benzophenone-3 10% pet
2-ethyl hexyl-4-methoxycinnamate 10% pet
2-hydroxy-4-methoxy-4-methyl-benzophenone 10% pet
Phenyl benzimidazole sulfonic acid 10% pet
Octyl triazone 10% pet
Drometrizole trisiloxane 10% pet
Octocrylene 10% pet
Octyl salicylate 5% pet
Ethylhexyltriazone 10% pet
Isoamyl-p-methoxy cinnamate 10% pet
Bis-ethylhexyloxyphenol methoxyphenyl triazine 10% pet
Methylene bis-benzotriazolyl tetramethyl butyl phenol 10% pet
2-(4-Diethylamino-2 hydroxybenzoyl) benzoic acid hexylester 10% pet
Diethyl hexyl butamido triazone 10% pet

*Approved by the Contact Dermatitis and Occupational Dermatoses Forum of India (CODFI)

Table 3.

International sunscreen series (updated in January 2014)*

Patch test antigens Conc. (w/w) Veh.
Butyl-methoxy-dibenzoyl methane (Parsol 1789, Eusolex 9020) 10.0% pet
4-aminobenzoic acid (PABA) 10.0% pet
Homosalate 5.0% pet
4-methylbenzyliden camphor (Eusolex 6300) 10.0% pet
Ethylhexyl dimethyl PABA 10.0% pet
Benzophenone-3 (Eusolex 4360, Escalol 567, Oxybenzone) 10.0% pet
Ethylhexyl methoxycinnamate (Parsol MCX, Escalol 55) 10.0% pet
Benzophenone-10 10.0% pet
Phenylbenzimidazol-sulfonic acid (Eusolex 232, Novantisol) 10.0% pet
Benzophenone-4 (sulisobenzone, Uvinyl MS-40) 2.0% pet
Drometrizole trisiloxane 10.0% pet
Octocrylene 10.0% pet
Ethylhexyl salicylate 5.0% pet
Ethylhexyl triazone 10.0% pet
Isoamyl-p-methoxycinnamate 10.0% pet
Bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S) 10.0% pet
Methylene-bis-benzotriazolyl tetramethylbutylphenol (Tinosorb M) 10.0% pet
2-(4-Diethylamino-2 hydroxybenzoyl) benzoic acid hexylester (Uvinul A+) 10.0% pet
Diethylhexyl butamido triazone (Uvasorb HEB) 10.0% pet
Disodium phenyl dibenzimidazole tetrasulfonate (Neo Heliopan AP) 10.0% pet
Decyl glucoside 5.0% pet

*This series is a selection of haptens (UV blockers) found in skincare products that protect against the sun and is authorized by the International Contact Dermatitis Research Group (ICDRG) for patch test/photopatch test and marketed by Chemotechnique MB Diagnostics AB, Vellinge, Sweden (www.chemotechnique.se)

Two sets of test allergens are placed over the back as in standard patch testing for photopatch testing. After 48 h of occlusion, one set of allergens is removed, and the site is irradiated with UV-A 5–10J/cm2, depending on skin phototypes. However, apart from irritant reactions false-positive/-negative reactions are possible because of the improper selection of the UV-A dose. Some workers consider that the concentration of an allergen is more important for eliciting a photo response than the actual dose of UV-A and recommend to use of 5 J/cm2 for photopatch testing.[81] A positive reaction from allergens on both sets reflects contact allergy with and without photo-aggravation, whereas photoallergy is confirmed when only the irradiated site shows a reaction. A careful interpretation of results is imperative in patients who develop positive responses from the UV-A dose alone (masked patch test).[20] For patients exhibiting negative/doubtful patch test results despite a strong suspicion of sunscreen sensitivity, a “usage test” or repeated open application test (ROAT) are useful diagnostic tools; the latter must be performed for 2‒3 weeks for weak allergens.

Treatment

Topical corticosteroids of mild to moderate potency, antihistamines for pruritus, and identification and avoidance of the culprit allergen(s) remain the first-line treatments for sunscreen ACD/PACD. Apprising patients of putative allergens, their synonyms, similar antigens, and available alternatives are crucial in long-term management. Patients must be made aware of sunscreen chemicals such as benzophenone added in personal care products primarily not meant for photoprotection (antiwrinkle/antiaging creams, face creams, skin whitening/anti-tanning creams, lip balms, daily moisturizing creams/lotions, shower gels, conditioners, and shampoos/hair care products). The new tinted/physical sunscreens, which are inert and cosmetically acceptable, can be prescribed when essential. Covering skin with apparel made of densely woven fabric of darker shades and using umbrellas/broad-brimmed hats as additional sun protection measures need emphasis, especially for children when outdoors.[82]

Guided Opinion for Optimal Use of Sunscreens

  1. Sunlight sensitivity is traditionally assessed by Fitzpatrick’s skin types [Table 4], and recommendations for sunscreen usage in adults can be simplified by classifying photo-sensitive persons into one of the three groups [Table 5].

  2. Sunscreen usage is imperative for photosensitive disorders such as xeroderma pigmentosum or other DNA repair defects, porphyrias, albinism, LE, PLE, hydroa vacciniforme, actinic prurigo, CAD, solar urticaria, the intake of drugs with photosensitizing potential, and after cosmetic procedures as new skin is susceptible to photodamage.

  3. A sunscreen that has both UV-A/UV-B and visible light blockers, easy spreadability, high substantivity, a non-oily feel, is photostable and sweat/water resistant (lasting for >40 min), is non-comedogenic, cosmetically elegant, and affordable is considered ideal. Antioxidants (vitamins E and C, niacinamide) in sunscreen(s) reportedly improve efficacy.[83,84,85] Current tinted sunscreens are non-allergenic and cosmetically elegant, and a formulation matching skin tone/undertone can be selected. They offer superior protection against both UV-A1 and visible/blue light compared to chemical sunscreens.[86,87,88] However, ACD from the excipient(s) remains possible.

  4. At least 2mg/cm2 of sunscreen should be applied to the face and uncovered skin 15‒30 min before going outdoors, even on cloudy days, while indoors, or traveling in cars. As some sunscreen chemicals degrade in sunlight or lose efficacy, reapplication every 2‒3h is recommended during continued sun exposure. A repeat application is also needed after swimming and sweating, as it usually gets washed away.[7,82]

  5. The American Academy of Dermatology does not recommend sunscreen usage in children aged <6 months, but pregnancy is not a contraindication.[82,89] Since no sunscreen can filter out 100% of sunlight additional sun protection measures are recommended, which are also preferred for sun protection in children.

Table 4.

Fitzpatrick’s classification for sun-reactive skin types with special reference to the Indian population

Skin type Skin Color Reaction to UVA Reaction to sun Skin types applicable to Indian population

Unexposed skin color Approximate Population
Type I Caucasian; blond or red hair, freckles, fair skin, blue eyes Very sensitive Always burns easily, never tans, very fair - 0%
Type II Caucasian; blond or red hair, freckles, fair skin, blue eyes or green eyes Very sensitive Usually burns easily, tans with difficulty, fair skin tone Skin typeII and type III 5%
Type III Darker Caucasian, light-skinned Asian Sensitive Burns moderately, tans gradually, fair to medium skin tone Very fair-skinned 5-10%
Type IV Mediterranean, Asian, Hispanic Moderately sensitive Rarely burns, always tans well, medium skin tone Skin Type III and Type IV Fair-skinned 5%
Type V Middle Eastern, Latin, light-skinned black, Indian Minimally sensitive Very rarely burns, tans very easily, olive or dark skin tone Skin Type IV and Type V Wheatish to dark-skinned 90%
Type VI Dark-skinned black Least sensitive Never burns, deeply pigmented, very dark skin tone - 0%

Table 5.

Recommendations for sunscreen usage

Groups Recommended Sun protection Characteristics of individuals requiring sunscreen use
Group 1 Maximum All individuals with
• Skin type I
• Skin types II and III involved in high outdoor activity; skiers, hikers, mountaineers, farmworkers, fishermen, lifeguards, sea surfers, and beach visitors, etc.
• Photosensitivity disorders.
• Previous history of skin cancer or precancerous changes.
• Desirous of shielding from photoaging.
• After cosmetic procedures (chemical peels, laser resurfacing, or dermabrasion).
Group 2 Moderate All individuals with
• Skin type II or III
• Skin types III and IV involved in minimal outdoor activity
Group 3 Minimal All individuals with
• Skin types II–IV who choose to tan
• Skin types V and VI

Notes:

Use of a broad-spectrum sunscreen having both UV-A/UV-B and visible light blockers, and an SPF* of at least 30 (SPF >50 offers no extra protection) is highly recommended.

*SPF, sun protection factor; defined as “the ratio of least amount of UVR energy needed to produce minimal erythema on unprotected skin and the same erythema on the skin protected by the sunscreen.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.Reitschel RL, Fowler JF., Jr . Photocontact dermatitis: Sunscreen agents. In: Reitschel RL, Fowler JF Jr, editors. Fisher's Contact Dermatitis. 6th ed. Ontario: B C Decker Inc; 2008. pp. 460–2. [Google Scholar]
  • 2.Victor FC, Cohen DE, Soter NA. A 20-year analysis of previous and emerging allergens that elicit photoallergic contact dermatitis. J Am Acad Dermatol. 2010;62:605–10. doi: 10.1016/j.jaad.2009.06.084. [DOI] [PubMed] [Google Scholar]
  • 3.Simonsen AB, Koppelhus U, Sommerlund M, Deleuran M. Photosensitivity in atopic dermatitis complicated by contact allergy to common sunscreen ingredients. Contact Dermatitis. 2016;74:56–8. doi: 10.1111/cod.12477. [DOI] [PubMed] [Google Scholar]
  • 4.Nash JF. Human safety and efficacy of ultraviolet filters and sunscreen products. Dermatol Clin. 2006;24:35–51. doi: 10.1016/j.det.2005.09.006. [DOI] [PubMed] [Google Scholar]
  • 5.Schauder S, Ippen H. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis. 1997;37:221–32. doi: 10.1111/j.1600-0536.1997.tb02439.x. [DOI] [PubMed] [Google Scholar]
  • 6.Lyons AB, Trullas C, Kohli I, Hamzavi IH, Lim HW. Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens. J Am Acad Dermatol. 2021;84:1393–7. doi: 10.1016/j.jaad.2020.04.079. [DOI] [PubMed] [Google Scholar]
  • 7.Tuchinda C, Srivannaboon S, Lim HW. Photoprotection bywindow glass, automobile glass, and sunglasses. J Am Acad Dermatol. 2006;54:845–54. doi: 10.1016/j.jaad.2005.11.1082. [DOI] [PubMed] [Google Scholar]
  • 8.Butler ST, Fosko SW. Increased prevalence of left-sided skin cancers. J Am Acad Dermatol. 2010;63:1006–10. doi: 10.1016/j.jaad.2009.11.032. [DOI] [PubMed] [Google Scholar]
  • 9.Guan LL, Lim HW, Mohammad TF. Sunscreens and photoaging: A review of current literature. Am J Clin Dermatol. 2021;22:819–28. doi: 10.1007/s40257-021-00632-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mahmoud BH, Ruvolo E, Hexel CL, Liu Y, Owen MR, Kollias N, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130:2092–7. doi: 10.1038/jid.2010.95. [DOI] [PubMed] [Google Scholar]
  • 11.Kohli I, Zubair R, Lyons AB, Nahhas AF, Braunberger TL, Mokhtari M, et al. Impact of long-wavelength ultraviolet A1 and visible light on light-skinned individuals. Photochem Photobiol. 2019;95:1285–7. doi: 10.1111/php.13143. [DOI] [PubMed] [Google Scholar]
  • 12.Verallo-Rowell VM, Pua JM, Bautista D. Visible light photopatch testing of common photocontactants in female Filipino adults with and without melasma: A cross-sectional study. J DrugsDermatol. 2008;7:149–56. [PubMed] [Google Scholar]
  • 13.Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–6. doi: 10.1016/j.jdermsci.2007.01.009. [DOI] [PubMed] [Google Scholar]
  • 14.Noh TK, Choi SJ, Chung BY, Kang JS, Lee JH, Lee MW, et al. Inflammatory features of melasma lesions in Asian skin. J Dermatol. 2014;41:788–94. doi: 10.1111/1346-8138.12573. [DOI] [PubMed] [Google Scholar]
  • 15.Aldahan AS, Shah VV, Mlacker S, Nouri K. The history of sunscreen. JAMA Dermatol. 2015;151:1316. doi: 10.1001/jamadermatol.2015.3011. [DOI] [PubMed] [Google Scholar]
  • 16.Kaur CD, Saraf S. In vitro sun protection factor determination ofherbal oils used in cosmetics. Pharmacognosy Res. 2010;2:22–5. doi: 10.4103/0974-8490.60586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Drissi M, Carr E, Housewright C. Sunscreen: A brief walk through history. Proc (Bayl Univ Med Cent) 2021;35:121–3. doi: 10.1080/08998280.2021.1966602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Boukari F, Jourdan E, Fontas E, Montaudie H, Castela E, Lacour JP, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: A prospective randomized comparative trial. J Am Acad Dermatol. 2015;72:189–90.e1. doi: 10.1016/j.jaad.2014.08.023. [DOI] [PubMed] [Google Scholar]
  • 19.Saraswat A. Contact allergy to topical corticosteroids and sunscreens. Indian J Dermatol Venereol Leprol. 2012;78:552–9. doi: 10.4103/0378-6323.100520. [DOI] [PubMed] [Google Scholar]
  • 20.Scheuer E, Warshaw E. Sunscreen allergy: A review of epidemiology, clinical characteristics, and responsible allergens. Dermatitis. 2006;17:3–11. doi: 10.2310/6620.2006.05017. [DOI] [PubMed] [Google Scholar]
  • 21.Wong T, Orton D. Sunscreen allergy and its investigation. Clin Dermatol. 2011;29:306–10. doi: 10.1016/j.clindermatol.2010.11.002. [DOI] [PubMed] [Google Scholar]
  • 22.Avenel-Audran M. Sunscreen products: Finding the allergen. Eur J Dermatol. 2010;20:161–6. doi: 10.1684/ejd.2010.0865. [DOI] [PubMed] [Google Scholar]
  • 23.Hughes TM, Stone NM. Benzophenone 4: An emerging allergen in cosmetics and toiletries? Contact Dermatitis. 2007;56:153–6. doi: 10.1111/j.1600-0536.2007.01017.x. [DOI] [PubMed] [Google Scholar]
  • 24.Goossens A. Contact allergic reactions to cosmetics. J Allergy (Cairo) 2011;2011:467–71. doi: 10.1155/2011/467071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Berne B, Ros AM. 7 years experience of photopatch testing with sunscreen allergens in Sweden. Contact Dermatitis. 1998;38:61–4. doi: 10.1111/j.1600-0536.1998.tb05653.x. [DOI] [PubMed] [Google Scholar]
  • 26.Belenznay K, de Gannes G, Kalia S. Analysis of the prevalence of allergic contact dermatitis to sunscreens: A cohort study. J Cutan Med Surg. 2014;18:15–9. doi: 10.2310/7750.2013.13041. [DOI] [PubMed] [Google Scholar]
  • 27.Marks JG, Jr, Belsito DV, DeLeo VA, Fowler JF, Jr, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patch test results, 1998-2000. Am J Contact Dermat. 2003;14:59–62. [PubMed] [Google Scholar]
  • 28.Pratt MD, Belsito DV, DeLeo VA. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis. 2004;15:176–83. [PubMed] [Google Scholar]
  • 29.Warshaw EM, Wang MZ, Maibach HI, Belsito DV, Zug KA, Taylor JS, et al. Patch test reactions associated with sunscreen products and the importance of testing to an expanded series: Retrospective analysis of North American Contact Dermatitis Group data, 2001 to 2010. Dermatitis. 2013;24:176–82. doi: 10.1097/DER.0b013e3182983845. [DOI] [PubMed] [Google Scholar]
  • 30.Darvay A, White IR, Rycroft RJG, Jones AB, Hawk JL, McFadden JP. Photoallergic contact dermatitis is uncommon. Br J Dermatol. 2001;145:597–601. doi: 10.1046/j.1365-2133.2001.04458.x. [DOI] [PubMed] [Google Scholar]
  • 31.Journe F, Marguery MC, Rakotondrazafy J, El Sayed F, Bazex J. Sunscreen sensitization: A 5-year study. Acta Derm Venereol. 1999;79:211–3. doi: 10.1080/000155599750010995. [DOI] [PubMed] [Google Scholar]
  • 32.Ang P, Ng SK, Goh CL. Sunscreen allergy in Singapore. Am J Contact Dermat. 1998;9:42–4. [PubMed] [Google Scholar]
  • 33.Cook N, Freeman S. Report of 19 cases of photoallergic contact dermatitis to sunscreens seen at the skin and cancer foundation. Australas J Dermatol. 2001;42:257–9. doi: 10.1046/j.1440-0960.2001.00531.x. [DOI] [PubMed] [Google Scholar]
  • 34.Macías E, González AM, De Lamas C, Ponce V, Muñoz-Bellido F, Moreno E. Allergic contact dermatitis due to sensitisation to sunscreen in two infants. Allergol Immunopathol. 2013;41:419–20. doi: 10.1016/j.aller.2012.08.006. [DOI] [PubMed] [Google Scholar]
  • 35.Ferriols AP, Boniche A. Photoallergic eczema caused by sunscreens in a 12-year-old girl. Contact Dermatitis. 2000;43:229–30. [PubMed] [Google Scholar]
  • 36.Haylett AK, Chiang YZ, Nie Z, Ling TC, Rhodes LE. Sunscreen photopatch testing: A series of 157 children. Br J Dermatol. 2014;171:370–5. doi: 10.1111/bjd.13003. [DOI] [PubMed] [Google Scholar]
  • 37.Avenel-Audran M, Dutartre H, Goossens A, Jeanmougin M, Comte C, et al. Octocrylene: An emerging (photo) allergen. Arch Dermatol. 2010;146:753–7. doi: 10.1001/archdermatol.2010.132. [DOI] [PubMed] [Google Scholar]
  • 38.Waters AJ, Sandhu DR, Lowe G, Ferguson J. Photocontact allergy to PABA in sunscreens: The need for continued vigilance. Contact Dermatitis. 2009;60:170–3. doi: 10.1111/j.1600-0536.2008.01448.x. [DOI] [PubMed] [Google Scholar]
  • 39.Sung CR, Kim KB, Lee JY, Lee BM, Kwack SJ. Risk assessment of ethylhexyl dimethyl PABA in cosmetics. Toxicol Res. 2019;35:131–6. doi: 10.5487/TR.2019.35.2.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pigatto PD, Guzzi G, Schena D, Guarrera M, Foti C, Francalanci S, et al. Photopatch tests: An Italian multicentre study from 2004to 2006. Contact Dermatitis. 2008;59:103–8. doi: 10.1111/j.1600-0536.2008.01374.x. [DOI] [PubMed] [Google Scholar]
  • 41.Bryden AM, Moseley H, Ibbotson SH, Chowdhury MM, Beck MH, Bourke J, et al. Photopatch testing of 1155 patients: Results of the U. K. multicentre photopatch study group. Br J Dermatol. 2006;155:737–47. doi: 10.1111/j.1365-2133.2006.07458.x. [DOI] [PubMed] [Google Scholar]
  • 42.Szczurko C, Dompmartin A, Michel M, Moreau A, Leroy D. Photocontact allergy to oxybenzone: Ten years of experience. Photdermatol Photoimmunol Photomed. 1994;10:144–7. [PubMed] [Google Scholar]
  • 43.Fidanzi C, Iannone M, Tonini G, Romanelli M, Dini V, Janowska A. An adult with allergic contact dermatitis from octocrylene in a sunscreen. Photodermatol Photoimmunol Photomed. 2023;39:397–9. doi: 10.1111/phpp.12842. [DOI] [PubMed] [Google Scholar]
  • 44.de Groot AC, Roberts DW. Contact and photocontact allergy to octocrylene: A review. Contact Dermatitis. 2014;70:193–204. doi: 10.1111/cod.12205. [DOI] [PubMed] [Google Scholar]
  • 45.Singh M, Beck MH. Octyl salicylate: A new contact sensitivity. Contact Dermatitis. 2007;56:48. doi: 10.1111/j.1600-0536.2007.00942.x. [DOI] [PubMed] [Google Scholar]
  • 46.Haisma MS, Schttelaar ML. Contact urticaria caused by the ultraviolet absorber octocrylene in sunscreens. Contact Dermatitis. 2017;77:254–6. doi: 10.1111/cod.12806. [DOI] [PubMed] [Google Scholar]
  • 47.Shaw DW. Allergic contact dermatitis from octisalate and cis-3-hexenyl salicylate. Dermatitis. 2006;17:152–5. doi: 10.2310/6620.2006.05046. [DOI] [PubMed] [Google Scholar]
  • 48.Hughes TM, Martin JA, Lewis VJ, Stone NM. Allergic contact dermatitis to drometrizole trisiloxane in a sunscreen with concomitant sensitivities to other sunscreens. Contact Dermatitis. 2005;52:226–7. doi: 10.1111/j.0105-1873.2005.0566a.x. [DOI] [PubMed] [Google Scholar]
  • 49.González-Pérez R, Trébol I, García-Río I, Arregui MA, Soloeta R. Allergic contact dermatitis from methylene-bis-benzotriazolyl tetramethylbutylphenol (Tinosorb M) Contact Dermatitis. 2007;56:121. doi: 10.1111/j.1600-0536.2007.00961.x. [DOI] [PubMed] [Google Scholar]
  • 50.Sommer S, Wilkinson SM, English JS, Ferguson J. Photoallergic contact dermatitis from the sunscreen octyl triazone. Contact Dermatitis. 2002;46:304–5. doi: 10.1034/j.1600-0536.2002.460514.x. [DOI] [PubMed] [Google Scholar]
  • 51.Nedorost S. Ensulizole (phenylbenzimidazole-5-sulfonic acid) asa cause of facial dermatitis: Two cases) Dermatitis. 2005;16:148. doi: 10.1097/01206501-200509000-00014. [DOI] [PubMed] [Google Scholar]
  • 52.Heurung AR, Raju SI, Warshaw EM. Benzophenones. Dermatitis. 2014;25:3–10. doi: 10.1097/DER.0000000000000025. [DOI] [PubMed] [Google Scholar]
  • 53.Sasseville D, Nantel-Battista M, Molinari R. Multiple contact allergies to benzophenones. Contact Dermatitis. 2011;65:179–81. doi: 10.1111/j.1600-0536.2011.01941.x. [DOI] [PubMed] [Google Scholar]
  • 54.Hanson JL, Warshaw EM. Sensitivity to multiple benzophenone sunscreen agents. Dermatitis. 2015;26:192–4. doi: 10.1097/DER.0000000000000131. [DOI] [PubMed] [Google Scholar]
  • 55.DiNardo JC, Downs CA. Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone/benzophenone-3. J Cosmet Dermatol. 2018;17:15–9. doi: 10.1111/jocd.12449. [DOI] [PubMed] [Google Scholar]
  • 56.Zhang XM, Nakagawa M, Kawai K, Kawai K. Erythema multiforme-like eruption following photoallergic contact dermatitis from oxybenzone. Contact Dermatitis. 1998;38:43–4. doi: 10.1111/j.1600-0536.1998.tb05637.x. [DOI] [PubMed] [Google Scholar]
  • 57.Bourrain JL, Amblard P, Beani JC. Contact urticaria photoinducedby benzophenones. Contact Dermatitis. 2003;48:45–6. doi: 10.1034/j.1600-0536.2003.480108_1.x. [DOI] [PubMed] [Google Scholar]
  • 58.Emonet S, Pasche-Koo F, Perin-Minisini MJ, Hauser C. Anaphylaxis too xybenzone, a frequent constituent of sunscreens. J AllergyClin Immunol. 2001;107:556–7. doi: 10.1067/mai.2001.112430. [DOI] [PubMed] [Google Scholar]
  • 59.Landers M, Law S, Storrs FJ. Contact urticaria, allergic contactdermatitis, and photoallergic contact dermatitis from oxybenzone. Am J Contact Dermat. 2003;14:33–4. doi: 10.2310/6620.2003.38769. [DOI] [PubMed] [Google Scholar]
  • 60.Agin PP, Ruble K, Hermansky SJ, McCarthy T. Rates of allergic sensitization and irritation to oxybenzone-containing sunscreen products: A quantitative meta-analysis of 64 exaggerated use studies. Photodermatol Photoimmunol Photomed. 2008;24:211–7. doi: 10.1111/j.1600-0781.2008.00363.x. [DOI] [PubMed] [Google Scholar]
  • 61.Tawfik ME, Atwater AR. Anaphylactoid raction to benzoheones, with recurrence during patch testing. Contact Dermatitis. 2019;81:303–4. doi: 10.1111/cod.13293. [DOI] [PubMed] [Google Scholar]
  • 62.Leonard F, Adamski H, Bonnevalle A, Bottlaender A, Bourrain JL, Goujon-Henry C, et al. [The prospective multicenter study on standard photopatch tests by the French Society of Photodermatology from 1991-2001] Ann Dermatol Venereol. 2005;132:313–20. doi: 10.1016/s0151-9638(05)79275-9. [DOI] [PubMed] [Google Scholar]
  • 63.Quartier S, Garmyn M, Becart S, Goossens A. Allergic contact dermatitisto copolymers in cosmetics-case report and review ofthe literature. Contact Dermatitis. 2006;55:257–67. doi: 10.1111/j.1600-0536.2006.00960.x. [DOI] [PubMed] [Google Scholar]
  • 64.Kai AC, White JM, White IR, Johnston G, McFadden JP. Contact dermatitis caused by C30-38 olefin/isopropyl maleate/MA copolymer in a sunscreen. Contact Dermatitis. 2011;64:353–4. doi: 10.1111/j.1600-0536.2010.01868.x. [DOI] [PubMed] [Google Scholar]
  • 65.Waas RLV, Hill G. Allergic contact dermatitis caused by vinylpyrrolidone/eicosene copolymer in a sunscreen. Contact Dermatitis. 2019;80:63. doi: 10.1111/cod.13127. [DOI] [PubMed] [Google Scholar]
  • 66.Le Coz CJ, Lefebvre C, Ludmann F, Grosshans E. Polyvinylpyrrolidone (PVP)/eicosene copolymer: An emerging cosmetic allergen. Contact Dermatitis. 2000;43:61–2. [PubMed] [Google Scholar]
  • 67.Stone N, Varma S, Hughes TM, Stone NM. Allergic contact dermatitis frompolyvinylpyrrolidone (PVP)/1-triacontene copolymer in asunscreen. ContactDermatitis. 2002;47:49. doi: 10.1034/j.1600-0536.2002.470111.x. [DOI] [PubMed] [Google Scholar]
  • 68.O’Connell M, Kirk S, Wilkinson MS. Allergic contact dermatitis caused by Tinosorb®M. Contact Dermatitis. 2011;65:48–9. doi: 10.1111/j.1600-0536.2011.01894.x. [DOI] [PubMed] [Google Scholar]
  • 69.Pereira N, Coutinho I, Andrade P, Gonçalo M. The UV filter tinosorb M, containing decyl glucoside, is a frequent cause of allergic contact dermatitis. Dermatitis. 2013;24:41–3. doi: 10.1097/DER.0b013e31827cd36f. [DOI] [PubMed] [Google Scholar]
  • 70.Aerts O, Clinck B, Schramme M, Lambert J. Contact allergy caused by Tinosorb®M: Let us not forget about xanthan gum. Contact Dermatitis. 2015;72:121–3. doi: 10.1111/cod.12324. [DOI] [PubMed] [Google Scholar]
  • 71.Esdaile B, Cooper SM. Allergic contact dermatitis caused by polyester-8 (Polycrylene®) in a sunscreen moisturizer. Contact Dermatitis. 2012;67:105–6. doi: 10.1111/j.1600-0536.2012.02067.x. [DOI] [PubMed] [Google Scholar]
  • 72.Hoffmann SS, Elberling J, Thyssen JP, Hansen KS, Johansen JD. Does aluminium in sunscreens cause dermatitis in children with aluminium contact allergy: A repeated open application test study. Contact Dermatitis. 2022;86:9–14. doi: 10.1111/cod.13973. [DOI] [PubMed] [Google Scholar]
  • 73.Badaoui A. Allergic contact dermatitis to aluminium in a sunscreen. Contact Dermatitis. 2023;89:305–7. doi: 10.1111/cod.14387. [DOI] [PubMed] [Google Scholar]
  • 74.Ghazavi MK, Johnston GA. Photo-allergic contact dermatitis caused by isoamyl p-methoxycinnamate in an 'organic'sunscreen. Contact Dermatitis. 2011;64:115–6. doi: 10.1111/j.1600-0536.2010.01839.x. [DOI] [PubMed] [Google Scholar]
  • 75.Monzón S, Abós T, Sáenz D, Pérez-Cinto N, Montijano R, Solano AM. Photoallergic contact dermatitis due to isoamyl-p-methoxycinnamate. J Investig Allergol Clin Immunol. 2009;19:415–6. [PubMed] [Google Scholar]
  • 76.Schram S, Glesne LA, Warshaw EM. Allergic contact cheilitis from benzophenone-2 in lip balm and fragrance/flavorings. Dermatitis. 2007;18:221–4. doi: 10.2310/6620.2007.06071. [DOI] [PubMed] [Google Scholar]
  • 77.Tracz ES, Sommerlund M, Bregnhøj A. Pustular allergic contact dermatitis caused by a sunscreen. Contact Dermatitis. 2020;83:328–9. doi: 10.1111/cod.13621. [DOI] [PubMed] [Google Scholar]
  • 78.Pastor-Nieto MA, Gatica-Ortega ME. Allergic contact dermatitis to drometrizole trisiloxane in a woman thereafter diagnosed with frontal fibrosing alopecia. Contact Dermatitis. 2023;89:215–7. doi: 10.1111/cod.14370. [DOI] [PubMed] [Google Scholar]
  • 79.Pastor-Nieto MA, Gatica-Ortega ME, Borrego L. Sensitisation to ethylhexyl salicylate: Another piece of the frontal fibrosing alopecia puzzle. Contact Dermatitis. 2024;90:402–10. doi: 10.1111/cod.14463. [DOI] [PubMed] [Google Scholar]
  • 80.Schmidt T, Ring J, Abeck D. Photoallergic contact dermatitis due to combined UVB (4-methylbenzyledine camphor/octylmethoxy cinnamate) and UVA (benzophenone3/butyl methoxydibenzoyl methane) absorber sensitization. Dermatology. 1998;196:354–7. doi: 10.1159/000017915. [DOI] [PubMed] [Google Scholar]
  • 81.Hasan T, Jansen CT. Photopatch test reactivity: Effect of photoallergen concentration and UVA dosaging. Contact Dermatitis. 1996;34:383–6. doi: 10.1111/j.1600-0536.1996.tb02237.x. [DOI] [PubMed] [Google Scholar]
  • 82.Hernandez LE, Mohsin N, Frech F, Nouri K. Sunscreen compliance with American Academy of Dermatology recommendations: A 2022 update and cross-sectional study. J Am Acad Dermatol. 2023;88:231–2. doi: 10.1016/j.jaad.2022.05.003. [DOI] [PubMed] [Google Scholar]
  • 83.Wang SQ, Osterwalder U, Jung K. Ex vivo evaluation of radical sun protection factor in popular sunscreens with antioxidants. JAm Acad Dermatol. 2011;65:525–30. doi: 10.1016/j.jaad.2010.07.009. [DOI] [PubMed] [Google Scholar]
  • 84.Lyons AB, Zubair R, Kohli I, Nahhas AF, Braunberger TL, Mokhtari M, et al. Mitigating visible light and long wavelengthUVA1-induced effects with topical antioxidants. Photochem Photobiol. 2022;98:455–60. doi: 10.1111/php.13525. [DOI] [PubMed] [Google Scholar]
  • 85.Navarrete-Solıs J, Castanedo-Cazares JP, Torres-Alvarez B, Oros-Ovalle C, Fuentes-Ahumada C, Gonzalez FJ, et al. Adouble-blind, randomized clinical trial of niacinamide 4% versushydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;2011:379173. doi: 10.1155/2011/379173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Bissonnette R, Nigen S, Bolduc C, Méry S, Nocera T. Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid. Dermatol Surg. 2008;34:1469–76. doi: 10.1111/j.1524-4725.2008.34311.x. [DOI] [PubMed] [Google Scholar]
  • 87.Schalka S, Steiner D, Ravelli FN, Steiner T, Terena AC, Marçon CR, et al. Brazilian Society of Dermatology. Brazilian consensus on photoprotection. An Bras Dermatol. 2014;89:1–74. doi: 10.1590/abd1806-4841.20143971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Ezekwe A, Pourang A, Lyons AB, Narla S, Atyam A, Zia S, et al. Evaluation of the protection of sunscreen products against long wavelength ultraviolet A1 and visible light-induced biological effects. Photodermatol Photoimmunol Photomed. 2024;40:e12937. doi: 10.1111/phpp.12937. [DOI] [PubMed] [Google Scholar]
  • 89.Shareef S, Boothby-Shoemaker W, Abdelnour A, Albazi E, Ashack K. Assessing public interest in sunscreen safety during pregnancy and lactation. Int J Womens Dermatol. 2022;19:e018. doi: 10.1097/JW9.0000000000000018. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Dermatology Online Journal are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES